Peregrine Pharmaceuticals, Inc. - Investor Relations

Investor Relations

Peregrine Pharmaceuticals, Inc.	Investor Relations/Corporate Communications
14282 Franklin Avenue, Tustin, CA 92780 Phone: 714-508-6000 Fax: 714-838-5817 info@peregrineinc.com	Amy Figueroa Tel: 800-987-8256 afigueroa@peregrineinc.com

Recent Press Releases

Jul 14, 2010
Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2010 Financial Results

Jul 14, 2010
Peregrine Initiates Second Randomized Phase IIb Lung Cancer Trial Using First-In-Class PS-Targeting Monoclonal Antibody Bavituximab

View all releases »

Upcoming Events

Sep 12, 2010
Rodman & Renshaw 12th Annual Healthcare Conference

View all events & presentations »

Transfer Agent

Integrity Stock Transfer
3265 E. Warm Spring Rd.
Las Vegas, NV 89120
Telephone: (702) 317-7757
Toll Free: (877) 317-7757
Fax: (702) 796-5650
Email: stock@integritynevada.net

Stock Information

NASDAQ:PPHM
$1.62 - 0.05

Jul 30, 2010
4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools

Shareholder Materials

To sign up for electronic delivery of shareholder materials click here

Executive Informational Overview^® on Peregrine